OAZ Regulates Bone Morphogenetic Protein Signaling through Smad6 Activation*

The intensity and duration of activation of a signal transduction system are important determinants of the specificity of the cellular response to the stimulus. It is unclear how different cells can generate a signal of varying intensity and duration in response to the same cytokine. We investigated the role of the transcriptional activator and Smad1/4 cofactor OAZ in regulating bone morphogenetic protein (BMP) signaling. We demonstrate that upon BMP4 stimulation, an OAZ-Smad1/4 complex binds to and activates the gene encoding Smad6, a specific inhibitor of the BMP pathway. Removal of endogenous OAZ from pluripotent embryonal carcinoma cells prevents the induction of Smad6 by BMP4 and extends the period of detection of phosphorylated Smad1 after BMP stimulation. Conversely, in cells that do not normally express OAZ, such as myoblasts and smooth muscle cells, forced OAZ expression leads to faster and higher Smad6 induction in response to BMP4, decrease of Smad1 phosphorylation, and attenuation of BMP-mediated responses. Our results demonstrate that OAZ can alter the intensity and duration of the BMP stimulus through Smad6 and indicate that the tissue-specific expression of OAZ is a critical determinant of the cellular response to the BMP signal.

[1]  R. Derynck,et al.  Regulation of Smad signalling by protein associations and signalling crosstalk. , 1999, Trends in cell biology.

[2]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[3]  Kathryn E. Hentges,et al.  Evi3, a zinc-finger protein related to EBFAZ, regulates EBF activity in B-cell leukemia , 2005, Oncogene.

[4]  C. Niehrs,et al.  The Xvent-2 homeobox gene is part of the BMP-4 signalling pathway controling dorsoventral patterning of Xenopus mesoderm , 1996 .

[5]  J. Massagué,et al.  Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. , 1998, Genes & development.

[6]  Manching Ku,et al.  Positive and Negative Regulation of the Transforming Growth Factor β/Activin Target Gene goosecoid by the TFII-I Family of Transcription Factors , 2005, Molecular and Cellular Biology.

[7]  P. Thistlethwaite,et al.  Molecular biology of primary pulmonary hypertension. , 2004, Cardiology clinics.

[8]  K. Miyazono,et al.  Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. , 2003, Molecular biology of the cell.

[9]  M. Speicher,et al.  A Cell-Based Screening Strategy That Predicts Mutations in Oncogenic Tyrosine Kinases: Implications for Clinical Resistance in Targeted Cancer Treatment , 2005, Cell cycle.

[10]  Jeffrey L. Wrana,et al.  Signal Transduction by the TGF-β Superfamily , 2002, Science.

[11]  K. Miyazono,et al.  Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. , 1999, Molecular biology of the cell.

[12]  J. Wozney,et al.  Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Hata,et al.  Indian Hedgehog Gene Is a Target of the Bone Morphogenetic Protein Signaling Pathway* , 2004, Journal of Biological Chemistry.

[14]  K. Miyazono,et al.  Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia , 2004, The Journal of cell biology.

[15]  R. Kageyama,et al.  BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Nordheim,et al.  Id Genes Are Direct Targets of Bone Morphogenetic Protein Induction in Embryonic Stem Cells* , 1999, The Journal of Biological Chemistry.

[17]  M. Humbert,et al.  BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. , 2001, American journal of human genetics.

[18]  M. Matzuk,et al.  Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. , 1999, Development.

[19]  P. Dijke,et al.  New insights into TGF-β–Smad signalling , 2004 .

[20]  W. Gerald,et al.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts , 1999, Nature.

[21]  J. Smith,et al.  Xom: a Xenopus homeobox gene that mediates the early effects of BMP-4. , 1996, Development.

[22]  M. d’Ortho,et al.  Pathobiology of pulmonary arterial hypertension , 2002, European Respiratory Journal.

[23]  K. Miyazono,et al.  Smad6 Is a Smad1/5-induced Smad Inhibitor , 2000, The Journal of Biological Chemistry.

[24]  M. Humbert,et al.  Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family , 2000, Journal of medical genetics.

[25]  N. Copeland,et al.  Early B-cell factor-associated zinc-finger gene is a frequent target of retroviral integration in murine B-cell lymphomas , 2004, Oncogene.

[26]  Myles Brown,et al.  Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.

[27]  K. Miyazono,et al.  Smad6 inhibits signalling by the TGF-β superfamily , 1997, Nature.

[28]  J. Massagué,et al.  OAZ Uses Distinct DNA- and Protein-Binding Zinc Fingers in Separate BMP-Smad and Olf Signaling Pathways , 2000, Cell.

[29]  C. Deng,et al.  Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. , 1999, Development.

[30]  C. Niehrs,et al.  Transcriptional regulation of BMP4 synexpression in transgenic Xenopus , 2004, The EMBO journal.

[31]  T. Nakayama,et al.  Smad6 functions as an intracellular antagonist of some TGF‐β family members during Xenopus embryogenesis , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[32]  C. Niehrs,et al.  Requirement for Xvent-1 and Xvent-2 gene function in dorsoventral patterning of Xenopus mesoderm. , 1998, Development.

[33]  V. Rosen,et al.  Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128(4):following 713] , 1994, The Journal of cell biology.

[34]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[35]  C. Hill,et al.  Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrest , 2003, Oncogene.

[36]  A. Hata,et al.  Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells. , 2004, Blood.

[37]  Ken W. Y. Cho,et al.  Phylogenetic footprinting and genome scanning identify vertebrate BMP response elements and new target genes. , 2005, Developmental biology.

[38]  A. Suzuki,et al.  Concentration-dependent patterning of the Xenopus ectoderm by BMP4 and its signal transducer Smad1. , 1997, Development.

[39]  K. Miyazono,et al.  Induction of Smad6 mRNA by bone morphogenetic proteins. , 1998, Biochemical and biophysical research communications.

[40]  C. Deng,et al.  Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. , 2001, Developmental biology.

[41]  A. Hata,et al.  Poly(ADP-ribose) polymerase 1 interacts with OAZ and regulates BMP-target genes. , 2003, Biochemical and biophysical research communications.

[42]  Steven Dyson,et al.  The Interpretation of Position in a Morphogen Gradient as Revealed by Occupancy of Activin Receptors , 1998, Cell.